Novartis: all 3,900 studies
Page 28 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy VolunteersCompletedNCT01529294Phase 1
- Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)CompletedNCT01528241Phase 1
- Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectionCompletedNCT01524341Phase 2
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsCompletedNCT01518101Phase 4
- Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedNCT01497522Phase 3
- Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast CancerTerminatedNCT01495247Phase 1/2
- Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491932Phase 2
- Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491529Phase 2
- Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsCompletedNCT01487785Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic PatientsCompletedNCT01487460Phase 1
- Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)CompletedNCT01483014Phase 2
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid TumorsCompletedNCT01482156Phase 1
- Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)CompletedNCT01482143Phase 1
- Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseCompletedNCT01474421Phase 2
- A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT01473901Phase 1
- A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabCompletedNCT01471847Phase 1
- Phase I Dose Escalating Study of TKI258CompletedNCT01471548Phase 1
- Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of AgeCompletedNCT01470287Phase 3
- A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST PatientsCompletedNCT01468688Phase 1
- Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and HospitalizationsWithdrawnNCT01460862
- Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study CentersWithdrawnNCT01460849
- Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic FibrosisCompletedNCT01460836
- Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy SubjectsCompletedNCT01459250Phase 1
- A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01456689Phase 1
- Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior TherapyCompletedNCT01456676Phase 1
- A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01456663Phase 1
- Safety of MenACWY-CRM Vaccination in AdolescentsCompletedNCT01452464
- Safety Surveillance of MenACWY-CRM Vaccine in ChildrenCompletedNCT01452438
- Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut AllergyWithdrawnNCT01451450Phase 2
- Safety, Tolerability and Efficacy of BFH772 in Rosacea PatientsCompletedNCT01449591Phase 2
- Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric PatientsCompletedNCT01447485Phase 1
- Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic FunctionCompletedNCT01443481Phase 1
- An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy SubjectsCompletedNCT01442259Phase 1
- Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying TherapiesCompletedNCT01442194
- Sickle Cell Disease: A Retrospective Chart ReviewCompletedNCT01441375
- Dose Finding Study for QAW039 in AsthmaCompletedNCT01437735Phase 2
- Safety and Tolerability of BVS857 in Subjects With Insulin ResistanceCompletedNCT01435330Phase 1
- Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01433458Phase 1
- Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosisCompletedNCT01433445Phase 1
- Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma PatientsCompletedNCT01430416Phase 1
- PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic FunctionCompletedNCT01429337Phase 1
- Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple MyelomaCompletedNCT01428492Phase 1
- A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton SyndromeCompletedNCT01428297Phase 1
- Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminCompletedNCT01426802Phase 4
- Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisCompletedNCT01423110Phase 2
- Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly SubjectsCompletedNCT01422512Phase 3
- Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid TumorsCompletedNCT01421004Phase 1
- Fingolimod -Response According to Coping - EvaluationCompletedNCT01420055Phase 4
- Drug Use Investigation for REVOLADE (ITP)CompletedNCT01416311
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01407003Phase 1/2
- Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean ChildrenCompletedNCT01404962Phase 4
- Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell LymphomaTerminatedNCT01402440Phase 1
- Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive PatientsTerminatedNCT01402401Phase 2
- Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering EfficacyCompletedNCT01398592Phase 4
- Observation of Patients With Transfusional Hemosiderosis Treatment With DeferasiroxCompletedNCT01394029
- Real-world Aliskiren Use in Diabetic PatientsCompletedNCT01393860
- A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of AfinitorCompletedNCT01390519
- A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C PatientsTerminatedNCT01387958Phase 2
- A Study of BYL719 in Adult Patients With Advanced Solid MalignanciesCompletedNCT01387321Phase 1
- Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01385592Phase 2
- Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head ComparisonCompletedNCT01379677Phase 3
- Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein OcclusionCompletedNCT01377597Phase 3
- Efficacy of Indacaterol 150 µg Versus FormoterolWithdrawnNCT01377428Phase 4
- Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mgCompletedNCT01376115
- Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis PatientsTerminatedNCT01375179Phase 2
- LFF269 Compared to Placebo After Treatment in Subjects With Essential HypertensionTerminatedNCT01373086Phase 2
- Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 TrialCompletedNCT01368523Phase 4
- Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)CompletedNCT01364415Phase 1
- Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic AsthmaCompletedNCT01362621
- Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly SubjectsCompletedNCT01357265Phase 2
- Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 DiabetesCompletedNCT01357252Phase 3
- Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 DiabetesCompletedNCT01356381Phase 4
- A Phase II Efficacy Study in Fistulizing Crohn's Disease PatientsCompletedNCT01355614Phase 2
- Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionCompletedNCT01353417
- A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsCompletedNCT01351103Phase 1
- Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerCompletedNCT01338831Phase 1
- Phase II BGG492 Capsule Extension for Partial EpilepsyCompletedNCT01338805Phase 2
- Study in Patients With Untreated Multiple Myeloma and Renal InsufficiencyCompletedNCT01337752Phase 2
- Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron OverloadCompletedNCT01335035Phase 4
- Drug Use Investigation for TYKERB Tablet (All Case Investigation)CompletedNCT01332396
- Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese ChildrenCompletedNCT01328886Phase 3
- Study to Evaluate the Long Term Use of Treatment With AIN457 for UveitisWithdrawnNCT01327664Phase 3
- Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorCompletedNCT01324492Phase 1
- Study of INC280 in Patients With c-MET Dependent Advanced Solid TumorsCompletedNCT01324479Phase 1
- ACZ885 in Type 1 Diabetes MellitusWithdrawnNCT01322321Phase 2
- Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant PatientsCompletedNCT01320358Phase 2
- Observe the Effectiveness and Safety of Ranibizumab in Real Life SettingCompletedNCT01318941
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular EdemaCompletedNCT01315275Phase 4
- Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisCompletedNCT01310166Phase 4
- Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesCompletedNCT01309698Phase 4
- Study of BHQ880 in Patients With High Risk Smoldering Multiple MyelomaCompletedNCT01302886Phase 2
- Study of BGG492 in Patients With Chronic Subjective TinnitusCompletedNCT01302873Phase 2
- Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) SymptomsCompletedNCT01300416
- A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid TumorsTerminatedNCT01299701Phase 1
- Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 InhibitorTerminatedNCT01299415Phase 1
- Ranibizumab "Treat and Extend" in Diabetic Macular EdmaCompletedNCT01297569Phase 4
- Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusCompletedNCT01294774Phase 2
- BEZ235 Trial in Patients With Advanced Endometrial CarcinomaWithdrawnNCT01290406Phase 2
- A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor MalignanciesTerminatedNCT01290380Phase 1